Melanoma, the potentially lethal form of skin cancer that can spread throughout the body, has a new enemy. The US Food & Drug Administration (FDA) has approved a new combination therapy.

Lung cancer is the leading cause of cancer-related death in the US. Advanced lung cancers have spread to other areas of the body and are extremely tough to beat. An experimental therapy may be a game changer.

One of every four deaths in the US is caused by cancer. Despite this fact, the number of cancer-related deaths has actually dropped in the last 20 years, with some groups seeing dramatic changes.

It stands to reason that the longer cancer remains in the body, the greater the chances it will grow and maybe spread. This is known to be the case for some cancers, but remains unclear for others.

Breast cancer patients with triple negative tumors may be harder to treat, but that doesn’t necessarily mean that radical surgery is needed.

A person’s risk of lung cancer plummets after kicking the cigarette habit. Unfortunately, the remaining risk isn’t zero. So, who should be screened for lung cancer and how often should they be screened?

Once the treatment for cancer is completed, the pain should be over, right? Not so for many breast cancer patients, according to the authors of a new European study.

Side effects involving skin damage have been reported in patients taking voriconazole for fungal infections. Some patients using voriconazole long-term have developed skin cancer.

Radiation therapy is regularly recommended for breast cancer patients as part of the breast cancer therapy regimen. Many women are not finishing this last step.

Cancers of the tongue and mouth are among the most common cancers diagnosed by doctors. One new study looked at the effectiveness of several treatment options for these cancers.